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Background: Candida glabrata is one of the most widespread Candida spp. associated to systemic 
candidiasis. This species is particularly critical in hospitalized, catheterized and immunosuppressed 
patients, due to a high drug resistance, specially to the azoles, but also to the ability to rapidly 
develop echinocandin resistance. 
 
Objectives: The goal of this work was to simulate a systemic infection exclusively derived from C. 
glabrata biofilm cells and to evaluate the effectiveness of two echinocandins  caspofungin (Csf) and 
micafungin (Mcf) - in its treatment. The host-pathogen response was also studied, by analyzing the 
inflammatory cell recruitment. 
 
Methods: CD1 mice were infected exclusively with 48 h-biofilm cells of C. glabrata and then treated 
with Csf or Mcf. After 72h, the efficacy of each drug was evaluated assessing organ fungal burden 
through CFU counting.  Moreover, the immune cell recruitment into target organs was evaluated by 
flow cytometry and histopathology analysis.  
 
Results: Fungal burden was higher in the liver than in the kidneys. Nevertheless, none of the drugs 
was effective in eradicating completely the infection.  At the evaluated time point, flow cytometry 
analysis, showed a predominant mononuclear response in the spleen, which was also evident in liver 
and kidneys of the infected mice, as observed by the histopathology analysis. Together, these 
observations confirmed C. glabrata as a low inflammatory species and indicated that two-dose 
treatment with Csf and Mcf do not have a significant impact on liver and kidney fungal burden, or 
recruited inflammatory infiltrate, when mice are i.v. infected with C. glabrata biofilm-grown cells. 
 
 
 
